Literature DB >> 28259694

Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation.

Pasquale Santangeli1, Francis E Marchlinski2.   

Abstract

The end point of current catheter-based ablation approaches for the treatment of atrial fibrillation (AF) is the elimination of all the possible triggers with the least amount of ablation necessary. Once all the triggers have been eliminated, the incremental value of any additional lesion sets remains to be proven. Pulmonary vein (PV) isolation is the cornerstone of catheter ablation approaches for eliminating AF triggers. However, up to 11% of patients demonstrate reproducible sustained AF initiation from non-PV foci. In these patients, triggers can typically be elicited using standardized induction protocols, which include cardioversion of spontaneous and/or induced AF and infusion of high-dose isoproterenol. Non-PV triggers typically arise from discrete anatomical structures that include the mitral and tricuspid periannular regions, the crista terminalis and Eustachian ridge, the interatrial septum, the left atrial (LA) posterior wall, the left atrial appendage (LAA), and other thoracic veins such as the superior vena cava, the coronary sinus, and the ligament of Marshall. Localization of non-PV foci involves a detailed analysis of specific intra-atrial activation sequences using multipolar catheters in standard atrial locations coupled with information from the surface electrocardiogram P wave when possible. Multipolar catheters positioned along the coronary sinus and crista terminalis/superior vena cava region together with direct recordings from the right and left PVs allow a quick localization of non-PV foci. Elimination of non-PV triggers by means of focal ablation at the site of origin or isolation of arrhythmogenic structures (eg, LA posterior wall or superior vena cava) has been associated with improved arrhythmia-free survival.
Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Mapping; Non–pulmonary vein triggers

Mesh:

Year:  2017        PMID: 28259694     DOI: 10.1016/j.hrthm.2017.02.030

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  36 in total

1.  Etiology, Pathology, and Classification of Atrial Fibrillation.

Authors:  Srishti Nayak; Balaji Natarajan; Ramdas G Pai
Journal:  Int J Angiol       Date:  2020-03-29

Review 2.  Approaches to Catheter Ablation of Nonparoxysmal Atrial Fibrillation.

Authors:  Jackson J Liang; Daniele Muser; Pasquale Santangeli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-07

Review 3.  Persistent atrial fibrillation: should we always ice the back of the left atrium?

Authors:  Kavisha Patel; Jorge Romero; Luigi Di Biase
Journal:  J Interv Card Electrophysiol       Date:  2019-07-24       Impact factor: 1.900

4.  [Pulmonary vein isolation using radiofrequency ablation].

Authors:  Leon Iden; Sonia Busch; Daniel Steven; Roland R Tilz; Dong-In Shin; K R Julian Chun; Heidi Estner; Felix Bourier; David Duncker; Philipp Sommer; Andreas Metzner; Tilman Maurer; Nils-Christian Ewertsen; Henning Jansen; Andreas Rillig; Victoria Johnson; Till Althoff
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-07-26

5.  Procedural Patterns and Safety of Atrial Fibrillation Ablation: Findings From Get With The Guidelines-Atrial Fibrillation.

Authors:  Zak Loring; DaJuanicia N Holmes; Roland A Matsouaka; Anne B Curtis; John D Day; Nihar Desai; Kenneth A Ellenbogen; Gregory K Feld; Gregg C Fonarow; David S Frankel; Jodie L Hurwitz; Bradley P Knight; Jose A Joglar; Andrea M Russo; Mandeep S Sidhu; Mintu P Turakhia; William R Lewis; Jonathan P Piccini
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-07-23

6.  Value of echocardiography in evaluating efficacy of radiofrequency catheter ablation in patients with atrial fibrillation.

Authors:  Ying Li; Bing Han; Jinfang Li; Fei Ge; Lianwei Yang
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 7.  Innovations in atrial fibrillation ablation.

Authors:  Jitae A Kim; Khurrum Khan; Riyad Kherallah; Shamis Khan; Ishan Kamat; Owais Ulhaq; Qussay Marashly; Mihail G Chelu
Journal:  J Interv Card Electrophysiol       Date:  2022-04-11       Impact factor: 1.900

8.  PRECAF Randomized Controlled Trial.

Authors:  Ling Kuo; David S Frankel; Aung Lin; Jeffrey Arkles; Matthew Hyman; Pasquale Santangeli; Francis E Marchlinski; Saman Nazarian
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-12-10

Review 9.  Imaging Techniques for the Study of Fibrosis in Atrial Fibrillation Ablation: From Molecular Mechanisms to Therapeutical Perspectives.

Authors:  Francesco De Sensi; Diego Penela; David Soto-Iglesias; Antonio Berruezo; Ugo Limbruno
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

10.  A modified percutaneous atrial balloon septoplasty for difficult transseptal puncture.

Authors:  Siyu Wang; Lei Zhao; Yuxing Wang; Xiandong Yin; Xinchun Yang; Ye Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.